You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Bpi Labs Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BPI LABS, and what generic alternatives to BPI LABS drugs are available?

BPI LABS has seven approved drugs.

There are three US patents protecting BPI LABS drugs. There is one tentative approval on BPI LABS drugs.

Summary for Bpi Labs

US Patents:	3
Tradenames:	7
Ingredients:	7
NDAs:	7

Drugs and US Patents for Bpi Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bpi Labs	EPINEPHRINE	epinephrine	SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS	205029-001	Jul 29, 2014		RX	Yes	Yes	9,283,197	⤷ Subscribe	Y		Y	⤷ Subscribe
Bpi Labs	ABLYSINOL	alcohol	SOLUTION;INTRA-ARTERIAL	207987-001	Jun 21, 2018		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Bpi Labs	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	mycophenolate mofetil hydrochloride	INJECTABLE;INJECTION	214283-001	Jun 1, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Bpi Labs	EPINEPHRINE	epinephrine	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	205029-005	Mar 4, 2024		RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Bpi Labs	PENTOBARBITAL SODIUM	pentobarbital sodium	INJECTABLE;INJECTION	206677-001	Nov 27, 2017	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Bpi Labs	MELPHALAN HYDROCHLORIDE	melphalan hydrochloride	INJECTABLE;INJECTION	209197-001	May 8, 2020	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Bpi Labs	NALOXONE HYDROCHLORIDE	naloxone hydrochloride	INJECTABLE;INJECTION	216977-001	Oct 6, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Bpi Labs

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.